ReviewFrontiers in immunology2021

Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections.

Amos C Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.